TY - JOUR AU - Koretsune, Y. AU - Yamashita, T. AU - Akao, M. AU - Atarashi, H. AU - Ikeda, T. AU - Okumura, K. PY - 2019 DA - 2019// TI - Baseline demographics and clinical characteristics in the all Nippon AF in the elderly (ANAFIE) registry JO - Circ J VL - 83 UR - https://doi.org/10.1253/circj.CJ-19-0094 DO - 10.1253/circj.CJ-19-0094 ID - Koretsune2019 ER - TY - JOUR AU - Lip, G. Y. H. AU - Collet, J. -. P. AU - Haude, M. AU - Byrne, R. AU - Chung, E. H. AU - Fauchier, L. PY - 2019 DA - 2019// TI - 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the EuropeanHeart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) JO - Europace VL - 21 UR - https://doi.org/10.1093/europace/euy174 DO - 10.1093/europace/euy174 ID - Lip2019 ER - TY - JOUR AU - Furugohri, T. AU - Isobe, K. AU - Honda, Y. AU - Kamisato-Matsumoto, C. AU - Sugiyama, N. AU - Nagahara, T. PY - 2008 DA - 2008// TI - DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles JO - J Thromb Haemost VL - 6 ID - Furugohri2008 ER - TY - JOUR AU - Giugliano, R. P. AU - Ruff, C. T. AU - Braunwald, E. AU - Murphy, S. A. AU - Wiviott, S. D. AU - Halperin, J. L. PY - 2013 DA - 2013// TI - Edoxaban versus warfarin in patients with atrial fibrillation JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1310907 DO - 10.1056/NEJMoa1310907 ID - Giugliano2013 ER - TY - JOUR AU - Bounameaux, H. AU - Camm, A. J. PY - 2014 DA - 2014// TI - Edoxaban: an update on the new oral direct factor Xa inhibitor JO - Drugs. VL - 74 UR - https://doi.org/10.1007/s40265-014-0261-1 DO - 10.1007/s40265-014-0261-1 ID - Bounameaux2014 ER - TY - JOUR AU - Sugidachi, A. AU - Asai, F. AU - Ogawa, T. AU - Inoue, T. AU - Koike, H. PY - 2000 DA - 2000// TI - The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties JO - Br J Pharmacol VL - 129 UR - https://doi.org/10.1038/sj.bjp.0703237 DO - 10.1038/sj.bjp.0703237 ID - Sugidachi2000 ER - TY - JOUR AU - Wiviott, S. D. AU - Braunwald, E. AU - McCabe, C. H. AU - Montalescot, G. AU - Ruzyllo, W. AU - Gottlieb, S. PY - 2007 DA - 2007// TI - Prasugrel versus Clopidogrel in patients with acute coronary syndromes JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa0706482 DO - 10.1056/NEJMoa0706482 ID - Wiviott2007 ER - TY - JOUR AU - Saito, S. AU - Isshiki, T. AU - Kimura, T. AU - Ogawa, H. AU - Yokoi, H. AU - Nanto, S. PY - 2014 DA - 2014// TI - Efficacy and safety of adjusted-dose Prasugrel compared with Clopidogrel in Japanese patients with acute coronary syndrome JO - Circ J VL - 78 UR - https://doi.org/10.1253/circj.CJ-13-1482 DO - 10.1253/circj.CJ-13-1482 ID - Saito2014 ER - TY - JOUR AU - Isshiki, T. AU - Kimura, T. AU - Ogawa, H. AU - Yokoi, H. AU - Nanto, S. AU - Takayama, M. PY - 2014 DA - 2014// TI - Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention JO - Circ J VL - 78 UR - https://doi.org/10.1253/circj.CJ-14-0266 DO - 10.1253/circj.CJ-14-0266 ID - Isshiki2014 ER - TY - JOUR AU - Otsuki, H. AU - Yamaguchi, J. AU - Kawamoto, T. AU - Yoshikawa, M. AU - Ebihara, S. AU - Tanaka, K. PY - 2019 DA - 2019// TI - Safety and efficacy of low-dose prasugrel as part of triple therapy with aspirin and Oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention — from the TWMU-AF PCI registry — JO - Circ J VL - 83 UR - https://doi.org/10.1253/circj.CJ-18-1113 DO - 10.1253/circj.CJ-18-1113 ID - Otsuki2019 ER - TY - JOUR AU - Vranckx, P. AU - Valgimigli, M. AU - Eckardt, L. AU - Tijssen, J. AU - Lewalter, T. AU - Gargiulo, G. PY - 2019 DA - 2019// TI - Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial JO - Lancet. VL - 394 UR - https://doi.org/10.1016/S0140-6736(19)31872-0 DO - 10.1016/S0140-6736(19)31872-0 ID - Vranckx2019 ER - TY - JOUR AU - Mielke, C. H. AU - Kaneshuro, M. M. AU - Maher, I. A. AU - Weiner, J. M. AU - Rapaport, S. I. PY - 1969 DA - 1969// TI - The standardized Normal ivy bleeding time and its prolongation by aspirin JO - Blood. VL - 34 UR - https://doi.org/10.1182/blood.V34.2.204.204 DO - 10.1182/blood.V34.2.204.204 ID - Mielke1969 ER - TY - JOUR AU - Mendell, J. AU - Lee, F. AU - Chen, S. AU - Worland, V. AU - Shi, M. AU - Samama, M. M. PY - 2013 DA - 2013// TI - The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor JO - J Cardiovasc Pharmacol VL - 62 UR - https://doi.org/10.1097/FJC.0b013e3182970991 DO - 10.1097/FJC.0b013e3182970991 ID - Mendell2013 ER - TY - JOUR AU - Kubitza, D. AU - Becka, M. AU - Mück, W. AU - Schwers, S. PY - 2012 DA - 2012// TI - Effect of co-administration of rivaroxaban and clopidogrel on bleeding time, pharmacodynamics and pharmacokinetics: a phase I study JO - Pharmaceuticals. VL - 5 UR - https://doi.org/10.3390/ph5030279 DO - 10.3390/ph5030279 ID - Kubitza2012 ER - TY - JOUR AU - Moll, F. AU - Baumgartner, I. AU - Jaff, M. AU - Nwachuku, C. AU - Tangelder, M. AU - Ansel, G. PY - 2018 DA - 2018// TI - Edoxaban plus aspirin vs dual antiplatelet therapy in endovascular treatment of patients with peripheral artery disease: results of the ePAD trial JO - J Endovasc Ther VL - 25 UR - https://doi.org/10.1177/1526602818760488 DO - 10.1177/1526602818760488 ID - Moll2018 ER - TY - JOUR AU - Gibson, C. M. AU - Mehran, R. AU - Bode, C. AU - Halperin, J. AU - Verheugt, F. W. AU - Wildgoose, P. PY - 2016 DA - 2016// TI - Prevention of bleeding in patients with atrial fibrillation undergoing PCI JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1611594 DO - 10.1056/NEJMoa1611594 ID - Gibson2016 ER - TY - JOUR AU - Caterina, R. AU - Lanza, M. AU - Manca, G. AU - Strata, G. AU - Maffei, S. AU - Salvatore, L. PY - 1994 DA - 1994// TI - Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding JO - Blood. VL - 84 UR - https://doi.org/10.1182/blood.V84.10.3363.3363 DO - 10.1182/blood.V84.10.3363.3363 ID - Caterina1994 ER - TY - JOUR AU - Barber, A. AU - Green, D. AU - Galluzzo, T. AU - Ts’ao, C. H. PY - 1985 DA - 1985// TI - The bleeding time as a preoperative screening test JO - Am J Med VL - 78 UR - https://doi.org/10.1016/0002-9343(85)90280-3 DO - 10.1016/0002-9343(85)90280-3 ID - Barber1985 ER -